Babay Pharma
Board
1 director, since incorporation- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 01-07-2024
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), appointed by deed of 01-07-2024, still in office
Control
Founders
,
This company
Babay Pharma
Equity €107,624
Profit €75,707 in 2025
Capital
- Contribution
- €30,000
- Shares
- 100
- Contribution per share
- €300
- Equity per share
- €1,076 in 2025
- Source
- deed of 01-07-2024
Articles of association
deed of 01-07-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Tenus solliciter agrément mêmes formalités si non de plein droit actionnaires”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 01-07-2024 ↗
- 90 shares (90%) · €27,000
- 10 shares (10%) · €3,000